Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2431952
Max Phase: Preclinical
Molecular Formula: C36H33F5N2O6S
Molecular Weight: 716.73
Molecule Type: Small molecule
Associated Items:
ID: ALA2431952
Max Phase: Preclinical
Molecular Formula: C36H33F5N2O6S
Molecular Weight: 716.73
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccccc1CN(CC(=O)N(Cc1ccc(C2CCCCC2)cc1)c1ccc(C(=O)O)c(O)c1)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1F
Standard InChI: InChI=1S/C36H33F5N2O6S/c1-21-7-5-6-10-25(21)19-42(50(48,49)35-33(40)31(38)30(37)32(39)34(35)41)20-29(45)43(26-15-16-27(36(46)47)28(44)17-26)18-22-11-13-24(14-12-22)23-8-3-2-4-9-23/h5-7,10-17,23,44H,2-4,8-9,18-20H2,1H3,(H,46,47)
Standard InChI Key: MLDRNTLPZBKFCA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 716.73 | Molecular Weight (Monoisotopic): 716.1979 | AlogP: 7.57 | #Rotatable Bonds: 11 |
Polar Surface Area: 115.22 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 2.85 | CX Basic pKa: | CX LogP: 8.60 | CX LogD: 5.11 |
Aromatic Rings: 4 | Heavy Atoms: 50 | QED Weighted: 0.09 | Np Likeness Score: -0.98 |
1. Page BD, Croucher DC, Li ZH, Haftchenary S, Jimenez-Zepeda VH, Atkinson J, Spagnuolo PA, Wong YL, Colaguori R, Lewis AM, Schimmer AD, Trudel S, Gunning PT.. (2013) Inhibiting aberrant signal transducer and activator of transcription protein activation with tetrapodal, small molecule Src homology 2 domain binders: promising agents against multiple myeloma., 56 (18): [PMID:23968501] [10.1021/jm3017255] |
Source(1):